CISD2 and metabolic dysfunction-associated steatotic liver disease: In the liver, one of our previous studies revealed that Cisd2 haploinsufficiency predisposes mice to the development of NAFLD and NASH with a 100% penetrance; this was found to occur in heterozygous mice carrying a hepatocyte-specific Cisd2KO (Cisd2hKO+/−).